Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

Fuat Polat

and 3 more

Background: This study aimed to compare patients with migraine and embolic stroke of undetermined source (ESUS) with known patent foramen ovale (PFO) in terms of echocardiographic and clinical features. Methods: In this observational single-center study, we obtained 2-dimensional (2D) and color Doppler images using parasternal short axis (PSAX), apical 4-chamber (A4C), and subcostal 4-chamber (SC4C) transthoracic echocardiography (TTE) views for patients with Migraine and ESUS. In cases where a PFO was suspected, patients underwent transthoracic contrast echocardiography and transesophageal echocardiography (TEE). We compared the anatomical and functional high-risk characteristics of PFO, as assessed by TEE and the RoPe score, in both patient groups. Results: This research involved a cohort of 720 individuals with ages ranging from 18 to 60, and 73.2% of the participants were female. Among the participants, 43.5% had Migraine, and 56.5% had ESUS. The most common comorbidity was diabetes (26.1%). PFO characteristics were measured, and high-velocity shunting through the interatrial septum was observed in 35.5% of patients. ESUS patients had a higher median age, with a similar gender distribution. ESUS patients had higher rates of diabetes and hypertension, while active smoking was more common in Migraine patients. Basic echocardiographic parameters were similar, except for higher pulmonary artery systolic pressure in ESUS. In the ESUS group, as compared to the migraine group, there was a more substantial occurrence of large microbubble passage through the interatrial septum, and the PFO showed increased length, while the PFO width remained similar. The RoPe and High-risk PFO scores were similar between the groups. Conclusions: ESUS patients were older with higher rates of diabetes and hypertension, while Migraine patients had a higher prevalence of active smoking. ESUS patients showed elevated pulmonary artery pressure, increased large microbubble crossings through the interatrial septum, and longer PFO lengths.

Fuat Polat

and 5 more

Objective: This retrospective study examined the relationship between atrial pacing parameters and atrial fibrillation (AF) occurrence in patients with sick sinus syndrome (SSS) who received dual-chamber pacemakers. Methods: Sixty SSS patients who underwent dual pacemaker implantation were studied. Demographics, clinical data, and device information were collected, and patients were followed for up to 2 years post-implantation. Statistical analyses assessed the association between atrial pacing parameters and AF development. Receiver operating characteristic (ROC) analysis identified potential predictors of AF, focusing on atrial pacing frequency and mode switch episodes. Results: Higher atrial pacing frequency significantly reduced AF risk at all time points (p<0.001), while lower pacing rates did not correlate with AF incidence. The number of atrial premature beats and mode switch episodes showed significant correlations with AF occurrence in the early post-implantation period but lost significance over time. Multivariable Cox regression analysis indicated that the number of atrial premature beats had no significant effect on AF development. However, an inverse relationship was observed between atrial pacing frequency and AF occurrence in the first and third months post-implantation. Conclusion: Maintaining a higher atrial pacing frequency emerges as a valuable strategy to reduce AF risk in dual-chamber pacemaker recipients with SSS. Notably, atrial premature beats and mode-switching episodes primarily influenced AF risk during the early post-implantation phase. This underscores the importance of monitoring and optimizing atrial pacing parameters, especially in the initial stages following pacemaker implantation, for effective AF management in SSS patients.